Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,256 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,466
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +7.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 601–650 of 1,865 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05562778	Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment	recruiting	N/A	150	Weill Medical College of Cornell UniversityOTHER	1	Jun 23, 2026	clinicaltrials
NCT07432633	[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications	recruiting	Phase 1 / Phase 2	71	Blue Earth DiagnosticsINDUSTRY	1	Jun 23, 2026	clinicaltrials